Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bismuth Subsalicylate for the Prevention of Travelers' Diarrhea
NCT03535272Phase 3Terminated
- Sponsor
- Centers for Disease Control and Prevention
- Start
- May 2018
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bismuth subsalicylate in traveler's diarrhea (TD), sponsored by Centers for Disease Control and Prevention. Started May 2018; status: terminated.
02
Drugs
bismuth subsalicylate
03
Conditions
traveler's diarrhea (TD)
Beyond the preview
Go deeper on NCT03535272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03535272.